DAVITA INC. Increase (Decrease) in Equity Securities, FV-NI
DAVITA INC. (DVA) reported Increase (Decrease) in Equity Securities, FV-NI of -$91.10 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi · last filed 2024-10-29
- DAVITA INC. increase (decrease) in equity securities, fv-ni for the quarter ending 2024-09-30 was -$36.35M.
- DAVITA INC. increase (decrease) in equity securities, fv-ni for the quarter ending 2024-06-30 was -$36.22M.
- DAVITA INC. increase (decrease) in equity securities, fv-ni for the quarter ending 2024-03-31 was -$18.53M.
- DAVITA INC. increase (decrease) in equity securities, fv-ni for the quarter ending 2023-09-30 was -$25.55M, a 5139.45% decline year-over-year.
| Period end | Increase (Decrease) in Equity Securities, FV-NI 3 month | Increase (Decrease) in Equity Securities, FV-NI 6 month | Increase (Decrease) in Equity Securities, FV-NI 9 month |
|---|---|---|---|
| 2024-09-30 | -$36.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$72.57M derived: sum of 2 quarters · filed 2024-10-29 | -$91.10M 10-Q · filed 2024-10-29 |
| 2024-06-30 | -$36.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$54.75M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | -$18.53M 10-Q · filed 2024-05-02 | ||
| 2023-09-30 | -$25.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$37.08M derived: sum of 2 quarters · filed 2024-10-29 | -$40.12M 10-Q · filed 2024-10-29 |
| 2023-06-30 | -$11.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$14.57M 10-Q · filed 2024-08-06 | |
| 2023-03-31 | -$3.04M 10-Q · filed 2024-05-02 | ||
| 2022-09-30 | $507.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.08M derived: sum of 2 quarters · filed 2023-11-07 | $417.00K 10-Q · filed 2023-11-07 |
| 2022-06-30 | $574.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$90.00K 10-Q · filed 2023-08-03 | |
| 2022-03-31 | -$664.00K 10-Q · filed 2023-05-08 | ||
| 2021-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31 | -$1.24M derived: sum of 2 quarters · filed 2022-10-31 | $1.69M 10-Q · filed 2022-10-31 |
| 2021-06-30 | -$160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $2.76M 10-Q · filed 2022-08-01 | |
| 2021-03-31 | $2.92M 10-Q · filed 2022-05-05 | ||
| 2020-09-30 | -$9.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$3.03M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $6.49M 10-Q · filed 2021-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |